drugset / Trial / NCT00405535
Adjunctive Glycine for Obsessive Compulsive Disorder
Completed
24 enrolled
Nathan Kline Institute for Psychiatric Research
Obsessive Compulsive Foundation · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether individuals with obsessive compulsive disorder who will take a preparation of the amino acid glycine in addition to their current treatment, may experience improvement in their symptoms.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycine | Other / unclassified | 60 g | Oral |